ROYAL BANK OF CANADA - SINGULAR GENOMICS SYSTEMS IN ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q3 2023$1,000
-50.0%
2,584
+0.1%
0.00%
Q2 2023$2,000
-66.7%
2,581
-50.4%
0.00%
Q1 2023$6,000
-73.9%
5,208
-52.9%
0.00%
Q4 2022$23,000
+228.6%
11,055
+312.5%
0.00%
Q3 2022$7,000
-78.1%
2,680
-67.8%
0.00%
Q2 2022$32,000
-13.5%
8,314
+41.1%
0.00%
Q1 2022$37,000
+12.1%
5,894
+106.7%
0.00%
Q4 2021$33,000
+22.2%
2,852
+19.7%
0.00%
Q3 2021$27,000
-10.0%
2,382
+121.6%
0.00%
Q2 2021$30,0001,0750.00%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Revelation Capital Management, LLC 2,219,951$14,008,00051.22%
ARCH Venture Management, LLC 3,798,926$23,971,0003.43%
Tikvah Management LLC 707,600$4,465,0001.43%
Triatomic Management LP 221,708$1,399,0001.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,612,019$41,722,0000.93%
Perceptive Advisors 3,655,207$23,064,0000.46%
Casdin Capital, LLC 1,442,870$9,105,0000.41%
Orbimed Advisors 2,300,792$14,518,0000.24%
Nicholas Investment Partners, LP 519,885$3,280,0000.23%
Alphabet Inc. 586,584$3,701,0000.12%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders